Literature DB >> 21200304

The economics of limb salvage in diabetes.

Nathan A Hunt1, George T Liu, Lawrence A Lavery.   

Abstract

BACKGROUND: Limb salvage requires early prevention therapy, knowledgeable use of wound care technology, and active management of peripheral vascular disease. This field has changed considerably over the past decade, with new advanced wound healing products and minimally invasive surgery for peripheral vascular disease. Treatment can be very costly in terms of medical and human resources. Evaluation of the clinical and economic impact of medical care is becoming more important as the population with diabetes and the need to contain the cost of health care simultaneously increase. The aim of this study was to review the economic impact of prevention therapies, wound care, and peripheral vascular disease interventions to prevent major lower extremity amputations.
METHODS: The authors reviewed the economic impact of prevention therapy, wound care, and peripheral vascular disease interventions to prevent lower extremity amputations.
RESULTS: Length of stay in the hospital and intensive care drive the cost of treatment. Surgical intervention and complications for foot ulcers, amputations, and peripheral vascular disease are significant factors in the cost of limb salvage.
CONCLUSIONS: Not surprisingly, prevention and evidenced-based treatments are the most cost-effective way of reducing the use of medical resources and improving and prolonging productive lifestyles. Future prospective studies need to be conducted to more accurately understand the financial impact of limb salvage.

Entities:  

Mesh:

Year:  2011        PMID: 21200304     DOI: 10.1097/PRS.0b013e3181fbe2a6

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

Review 1.  Cost of diabetic eye, renal and foot complications: a methodological review.

Authors:  Solène Schirr-Bonnans; Nadège Costa; Hélène Derumeaux-Burel; Jérémy Bos; Benoît Lepage; Valérie Garnault; Jacques Martini; Hélène Hanaire; Marie-Christine Turnin; Laurent Molinier
Journal:  Eur J Health Econ       Date:  2016-03-14

2.  Prevention of diabetic foot ulcer.

Authors:  Bijan Iraj; Fariborz Khorvash; Alireza Ebneshahidi; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2013-03

3.  Vascular surgery, microsurgery and supramicrosurgery for treatment of chronic diabetic foot ulcers to prevent amputations.

Authors:  Steffen Schirmer; Ralf-Gerhard Ritter; Hisham Fansa
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

4.  Towards a systems approach for chronic diseases, based on health state modeling.

Authors:  Michael Rebhan
Journal:  F1000Res       Date:  2017-03-23

5.  <Editors' Choice> Effects of exosomes derived from the induced pluripotent stem cells on skin wound healing.

Authors:  Hitoshi Kobayashi; Katsumi Ebisawa; Miki Kambe; Takatoshi Kasai; Hidetaka Suga; Kae Nakamura; Yuji Narita; Aika Ogata; Yuzuru Kamei
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

6.  Racial factors and inpatient outcomes among patients with diabetes hospitalized with foot ulcers and foot infections, 2003-2014.

Authors:  Ché Matthew Harris; Aiham Albaeni; Roland J Thorpe; Keith C Norris; Marwan S Abougergi
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.